SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015512
Filing Date
2023-04-28
Accepted
2023-04-28 09:41:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A for_filing_2023_defa14a.htm DEFA14A 22781
2 GRAPHIC img108323762_0.jpg GRAPHIC 5565685
3 GRAPHIC img108323762_1.jpg GRAPHIC 4382899
  Complete submission text file 0000950170-23-015512.txt   13726209
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39527 | Film No.: 23860941
SIC: 2834 Pharmaceutical Preparations